MERLIN is developing stem cell-based therapies that specifically target the inflammatory components of liver disease. Our partners BioInVision have developed a cryo-imaging system for 3D, microscopic imaging – the CryoViz instrument. CryoViz enables you to do cellular and molecular imaging where you get colour anatomy and exactly-registered multi-spectral molecular fluorescence. Check out our video, which shows […]
Author Archive for: merlin_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud merlin_admin contributed a whooping 52 entries.
Entries by merlin_admin
The group of Prof. Antonella Viola from University of Padua has recently published a review titled “Mesenchymal stem cells: myths and reality” in “Swiss Medical Weekly”, the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology and the Swiss Society of Rheumatology. In this review, they identified what […]
MERLIN will be presented in a bespoke session at EASL to highlight EU initiatives. An abstract we submitted to EASL has also been accepted as a parallel session oral presentation. The EASL 2016 Annual Meeting will be held in Barcelona 13-17 April 2016. EASL – The Home of Hepatology – is Europe’s preeminent liver association […]
The MERLIN team met at the Radisson Blu Hotel, Birmingham 28 – 29 January 2016 to discuss the results of our pre-clinical work. We discussed preparations for the MERLIN clinical trial, including results from our MSC bio-distribution studies, pre-clinical experiments, and progress on the GMP manufacture of our stem cell therapy for PSC. We were joined by three […]
MERLIN coordinating partner University of Birmingham (UoB) is a centre of excellence for stem cell therapy and home to the MRC Centre of Immune Regulation. The University also has an unrivaled programme of human liver research, run through the Centre for Liver Research. Check out this video, where you can learn more about the UoB […]
MERLIN researchers participated in the EU-MSC2 meeting in Leiden on the 7th and 8th of September 2015 The two-day meeting brought together researchers from nine EU-funded projects pursuing MSC research. In addition to REDDSTAR, other projects represented at the meeting included ADIPOA-2, REDDSTAR, VISICORT, Stellar, RETHRIM, REACH, MERLIN,SCIENCE and NEPHSTROM. After a welcome from Henri Lenferink, Mayor […]
EuroStemCell recently came up with a new way to get the most out of a public event – they turned their fact sheets into an exhibition. From the content of the fact sheets with their quality, trustworthy and double-checked information, they created colourful posters about stem cells, stem cell research and diseases. And it worked! […]
Coordinator Prof. Phil Newsome is featured in a new University of Birmingham article on tackling the twin deadly scourges of liver disease and diabetes. The article discusses how University of Birmingham researchers are spearheading efforts to tackle liver disease and diabetes; now recognised as two of the most serious global health epidemics, yet both ultimately […]
The MERLIN team met at the Venetian Institute of Molecular Medicine 01 – 02 October 2015 to discuss the results of our pre-clinical work, including work with MSC in vitro and in pre-clinical models of liver disease. Results from recent MSC bio-distribution studies were also presented. We discussed preparations for the MERLIN trial, including progress on the GMP manufacture of […]
MERLIN researchers attended the EU-MSC2 meeting in Leiden, 07 – 08 Sept 2015. The meeting brought together researchers from a number of EU-funded projects pursuing MSC research. Other projects represented included Stellar, RETHRIM, REACH, VISICORT, ADIPOA-2, REDDSTAR, SCIENCE and NEPHSTROM. The meeting included interactive panel discussions about key challenges faced when developing MSC therapies, including scientific […]
- Cells cultured in vitro have the same biological characteristics as the functional cells that line the bile duct t.co/oFyJoVhH0A Time ago 7 Days via Twitter Web Client
- Here is an interesting new text from the leaders of the Stromal Immunology Group: t.co/8kupRloqoF @stromalimmune Time ago 8 Days via Twitter Web Client
- @PSCSupportUK wants to see a world without Primary Sclerosing Cholangitis. #PSC is a rare autoimmune disease of the… t.co/gEqQtgEbCP Time ago 12 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.